Cambridge Antibody Technology and AstraZeneca

Uploaded by : Essays-Now.com

The deal between the pharmaceutical conglomerate AstraZeneca and its 19.9 percent purchase of the small biotechnology company known as Cambridge Antibody Technology is discussed in terms of benefits for each company, the alliance purpose, and how share prices will be affected. Eight sources are cited in the bibliography.